Clobetasol Propionate Ophthalmic Nanoemulsion 0.05% for the Treatment of Inflammation and Pain Associated With Cataract Surgery (CLOSE-2)
Condition: Cataract Interventions: Drug: Clobetasol Propionate; Drug: Vehicle Sponsor: Salvat Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cataract Removal | Cataracts | Clobetasol | Nanotechnology | Opthalmology | Pain | Research